La Commission européenne lance un appel destiné aux chercheurs confirmés.
Point de contact national : firstname.lastname@example.org
Date limite de candidature : 30 août 2018 à 17h (heure de Bruxelles)
The Ruth K. Broad Biomedical Research Foundation, Inc., a support corporation of Duke University, funds research in the neurosciences with a specific focus on investigation that may advance the knowledge or treatment of Alzheimer’s disease. Pilot studies that can lead to conventional funding are preferred, to focus the Foundation’s support on new rather than existing research.
*Extramural Award Application
Application Due: February 1, 2018
Next Award Period: July 1, 2018 – June 30, 2020
Eligibility: Young or established non-Duke University investigators proposing new or novel research.
The Foundation will be awarding a two-year grant, effective July 1, 2018, for $125,000 each year. Applications will be evaluated on their potential for advancing understanding of neurodegenerative disorders, with particular interest in the potential relationship to Alzheimer’s disease. The research proposed should be an innovative direction of study for the applicant’s lab with the potential for high impact on the field.
Request for Proposals and Applications Materials (PDF Document)
Request for Proposals and Applications Materials (Word Document)
*International Award Application
Applications are not currently being accepted for this award.
Next anticipated grant period begins July 1, 2019
The Ruth K. Broad Biomedical Research Foundation, Inc. funds an international (non–US origin) postdoctoral fellow for two years of research broadly related to neurodegenerative diseases. The award amount is based on the official NIH postdoctoral stipend schedule, plus $5,000 per year. The sponsoring laboratory will cover the cost of research supplies and operating expenses.
more information : http://www.mizutanifdn.or.jp/grant/apply.html
Deadline : 01/09/2018
+ infos : http://www.fondation-edmus.org/fr/
Research projects may address all aspects of spinal cord lesions, nerve regeneration, trophic support of injured neurons and functional changes induced by lesions (preferentially in mammals).
more information : http://www.wingsforlife.com/en/latest/grant-application-479/
A. Individual grants (salary of Post-docs, PhDs, and/or technicians)
B. Project research grants (personnel, equipment, consumables, etc
C. Wings for Life Accelerated Translational Program (ATP) (clinical trials)
Deadlines for Grant Proposals (Format A and B)
• Executive summary: September 2, 2018
• Full grant application: November 2, 2018
No deadlines for clinical proposals for the Accelerated Translational Program (ATP)
This grant program will be useful for junior faculty in the early stages of their careers, established investigators in other areas of research who wish to enter the field of PWS research, or investigators in the PWS field who are seeking funding to support pilot studies in a new area of PWS research.
All scientifically meritorious research related to PWS will be considered, but areas of particular interest include:
Genotype to phenotype: understanding PWS genetics / how loss of PWS-critical region genes leads to the phenotype
Neurobiology of hunger / feeding behavior in PWS
Neurobiology of cognitive deficits, maladaptive behavior and mental illness in PWS
Clinical care research: evaluation of existing drugs and interventions to improve health and quality of life in PWS
Therapeutics development for PWS- Genetic therapies; novel pharmaceuticals; drug repurposing for PWS
FPWR will also consider supporting the development of unique in vitro and in vivo resources and models, or bioinformatic capabilities to be shared with the PWS research community
Letters of Intent due September 14th, 2018
Proposals due November 15th, 2018
-Research Grant: One-year seed money grants of up to $15,000 but promising proposals up to a maximum of $30,000 will be considered for early or pilot phases of studies and ongoing investigations. Applicants for seed-money grants need to be faculty members.
July 16, 2018 – Date the Letter of Intent is due with a ½ to one-page abstract with specific aims of your research.
August 15, 2018 – Full application due
-Young Investigator (YI) Award: One-year grants* of $35,000 to encourage young investigators to pursue a career in the field of any form of Ataxia research.
For Young Investigator award programs, candidates must have attained an MD or PhD degree, and have an appointment as a junior faculty member, senior post-doc or clinical fellow. Individuals at the Associate Professor level are not eligible. Clinicians must have finished their residency no more than five years prior to applying. PhDs must be no more than five years from end of the completion of their post-doc training.
The sponsoring institution must agree in writing to the following provision: the young investigator (MD or PhD) must be free to allocate approximately half time (50%) for Ataxia related research.
August 1, 2018 – Date the Letter of Intent is due with a ½ to one-page abstract with specific aims of your research and the name of your mentor
September 4, 2018 – Full application due
-Research Post-Doc Fellowship Award: One-year grants* up to $35,000. Applicants should have completed at least one year of post-doctoral training, but not more than two at the time of application, and should have shown a commitment to research in the field of Ataxia.
August 15, 2018 – Date the Letter of Intent is due with a ½ to one-page abstract with specific aims of your researchand the name of your mentor
September 17, 2018 – Full application due
-Research grants :
Pre-applications due July 25; full applications due August 1, 5:00 pm EST
-Training Grants and Fellowships :
POSTDOCTORAL RESEARCH FELLOWSHIP
Deadline 2018: pre-applications due August 8; full applications due August 15, 5:00 pm EST
Citizenship: U.S. citizenship is not required for applicants who desire training in institutions in the United States. However, applicants who plan training in other countries must be U.S. citizens. Applicants may submit dual applications to governmental granting agencies and other non-profit funding agencies.
MENTOR-BASED POSTDOCTORAL FELLOWSHIP PROGRAM IN REHABILITATION RESEARCH
Deadline 2018: pre-applications due July 25; full applications due August 1, 5:00 pm EST
Citizenship: U.S. citizenship is not required either for mentors or postdoctoral fellows working at institutions in the United States. Mentors and institutions outside the United States may apply to this program but are requested to submit dual applications to governmental granting agencies and/or other non-profit funding agencies in their own country.
-Prizes and awards
THE JOHN DYSTEL PRIZE FOR MULTIPLE SCLEROSIS RESEARCH
All investigators who are actively engaged in fundamental or clinical research related to multiple sclerosis are eligible for nomination for this prize.
Deadline: November 1, annually.
HFSP postdoctoral fellowships encourage early career scientists to broaden their research skills by moving into new areas of study while working in a new country.
The next fellowship deadline will be in August or September 2018.
HFSP fellowships are for three years. Fellows may choose to stay for up to three years in the host country or use the last year of their fellowship to return to their home country or to move to another HFSPO member country.
Long-Term Fellowships (LTF) are for applicants with a Ph.D. in a biological discipline, who will broaden their expertise by proposing a project in the life sciences which is significantly different from their previous Ph.D. or postdoctoral work.
Cross-Disciplinary Fellowships (CDF) are for applicants with a Ph.D. from outside the life sciences (e.g. in physics, chemistry, mathematics, engineering or computer sciences), who have had limited exposure to biology during their previous training.
Clinical Neuroscience Research :
Deadline: Preliminary proposals for the Clinical Neuroscience Research program may be submitted at any time.
Funding: up to $300,000 payable over 3 years
The Clinical Neuroscience Research program tends to focus on:
1) translating promising animal model interventions or clinical observations for treating devastating brain conditions or injuries into small-sale studies in humans with these conditions to see if the intervention shows any effect, and designing neuroethical guidelines for such studies;
2) identifying functions of specific neurons and neural networks involved in brain diseases or injuries and developing therapeutic interventions to alter these; and
3) assessing outcomes of the effects of various therapies used to treat brain injuries, such as stroke. The program also occasionally considers studies of complex cognitive processes, such as creativity.
LOI: late September
Full application: mid-January
ABTA Research Collaboration (ARC) Grant Program
ABTA Basic Research Fellowship Program
ABTA Discovery Grant Program
-ABTA Research Collaboration (ARC) Grant Program
ARC Grants are two year, $200,000 grants intended to promote team science in a way that will streamline and accelerate progress and affect the desired change in clinical outcome for brain tumors. Research projects supported under this mechanism must be conducted by a team of at least two co-principal investigators (Co-PI's) from distinct institutions. The research project should be multi-disciplinary in that it incorporates multiple components such as basic, translational, clinical and epidemiological research.
-ABTA Basic Research Fellowship ProgramBasic Research Fellowship Grants are two year, $100,000 grants supporting postdoctoral fellows conducting brain tumor research. Fellows must include a lead mentor who currently conducts brain tumor research at the same academic institution in an effort to provide research, scientific management and other leadership guidance necessary to foster the applicant’s career advancement.
-ABTA Discovery Grant ProgramDiscovery Grants are one year, $50,000 grants for investigators conducting high-risk/high-impact research deemed to have the potential to change current diagnostic or treatment paradigms. Investigators should be full-time faculty to apply.
Applications: March 1st and September 1st
Research Grant Guidelines
Funding: up to US$75,000.00 per year for two years.
Post Doctoral Fellowship Award
Funding: range of US$30,000-$40,000 per year for two years.
La Fondation pour l'aide à la recherche sur la sclérose en plaques lance un appel "Approche personnalisée, éthique, sociologique et économique de la sclérose en plaques par la recherche".
Montant : 150 000 €
Date limite de candidature : 27 septembre 2018
Alzheimer's Disease Research Grants: Standard Awards and Postdoctoral Fellowship Awards
Deadline: October 2, 2018
Cure Alzheimer’s Fund primarily supports invited proposals as referred by members of the Research Leadership Group (RLG). However, any qualified scientist may submit a one-page letter of inquiry to Cure Alzheimer’s Fund for review for fit with our scientific standards and research areas.
Letters of inquiry and proposals are accepted on a rolling basis; there is no set timeline for applications, funding decisions, or funding initiation.
Communications regarding Cure Alzheimer’s Fund applications and support should be sent to email@example.com.
Current areas of investigation that Cure Alzheimer’s Fund will support include:
-Alzheimer’s Genome Project and Functional Genomics
-Genes to Therapies™/Stem Cell Drug Screening: Translational studies investigating established and newly confirmed AD genes
-Identification: Early detection via biomarkers, imaging, etc.
-Immune System Structures and Processes: Role of inflammation and other responses in Alzheimer’s
-Interaction of the Microbiome with Alzheimer’s
-Pathological Pathways & Systems
-Therapeutic Strategies and Drug Discovery
- Whole Genome Sequencing and Epigenetics
-Other: Novel approaches, targets, or therapies aligned with the Cure Alzheimer’s Fund mission
Biomedical Research Project Grants
Funding research of the highest scientific merit and greatest relevance to MND
This round will open on 7 September 2018.
Deadline: 2 November 2018
Applicants can be based outside the UK and Ireland, provided the project is unique in concept or design (ie no similar research is being performed in the UK) and involves a significant aspect of collaboration with a UK institute.
The goal of the foundation is to provide research grants for the study of the understanding of the basic causes of the disease. These awards are not directed to clinically related projects for patient care. There is no geographical limitation to the recipients of these grants.
The Bruno and Ilse Frick Foundation for Research on ALS is calling for grant applications. The aim of the Foundation is to encourage basic biomedical research related to understanding the cause of amyotrophic lateral sclerosis (ALS) (100,000 CHF over 2 years).
Deadline: October 8, 2018
The NRC Associateship Programs
Awards are available for scientists and engineers at all stages of their career, representing the disciplines of Chemistry; Earth, Atmospheric and Space Sciences; Engineering, Applied Science, and Mathematics; Life Sciences; and Physics. Applicants should hold, or anticipate receiving, an earned doctorate in science or engineering. Degrees from universities abroad should be equivalent in training and research experience to a degree from a U.S. institution. Many awards are open to foreign nationals as well as to U.S. citizens.
Application Deadline* (5 PM ET):
SUDEP Biomarker Challenge Prize
Award: $1,000,000 USD
Deadline: 10 oct. 2020 23:59 EDT
In order to accelerate the identification of effective treatments for sudden unexpected death in epilepsy (SUDEP), the Epilepsy Foundation SUDEP Institute is sponsoring a Reduction to Practice Challenge to develop a predictive biomarker or panel of biomarkers to identify people at risk for SUDEP or seizures that compromise cardiac or respiratory function. The biomarker(s) must serve as an endpoint or surrogate endpoint that will drive human SUDEP interventions. For example, the biomarker(s) may identify a high risk patient group that could be used to test existing candidate interventions such as seizure detection devices.
Milestone 1 requires a detailed Project Plan of the proposed solution. Milestone 2 involves the production of proof-of-concept data. Milestone 3 requires results that demonstrate the predictive efficacy of the biomarker(s). The SUDEP Institute intends to make up to 10 awards from a total award pool of $100,000 for Milestone 1, up to 4 awards of $25,000 each for Milestone 2, and a final award at least $800,000 for successful completion of Milestone 3.
Solvers are encouraged to enter this Challenge even if they were not involved in The SUDEP Institute Challenge: Predictive Biomarkers of Epilepsy – Challenge 9933719. Participants from the previous Challenge may elect to expound upon their (winning) solution or pursue another idea. Solvers should note that the Center for SUDEP Research (CSR) is an NIH-funded research collaborative studying animal models of SUDEP and epilepsy patients who may be at high risk for SUDEP. Solvers may contact the CSR at firstname.lastname@example.org to request data and/or biospecimens to be used in the execution of a Solution. Other resources that Solvers may access are through the North American SUDEP Registry and the Center for Disease Control and Prevention (CDC) Sudden Death in the Young Registry.
Submission Deadlines – October 15 and April 15
L'appel FET Innovation Launchpad 2018-2019-2020 finance des projets pour explorer le potentiel d'innovation des résultats scientifiques des projets FET.
Montant : jusqu'à 100 000 € / projet
Date limite de candidature : 16 octobre 2018
Multiple Sclerosis (MS) Research Program
Investigator Initiated Research Award
The Investigator-Initiated Research Award supports highly rigorous, high-impact research projects that have the potential to make an important contribution to MS research and/or patient care. Research projects may focus on any phase of research, excluding clinical trials. The rationale for a research idea may be derived from laboratory discovery, clinical trial results, population-based studies, a clinician’s firsthand knowledge of patients, or anecdotal data. Applications must include preliminary and/or published data that are relevant to MS and the proposed research project.
Pre-Application (Preproposal): June 26, 2018
Preproposal is required; application submission is by invitation only.
Application: October 18, 2018
The Exploration – Hypothesis Development Award supports the initial exploration of innovative, high-risk, high-gain, and potentially groundbreaking concepts in the MS research field. The studies supported by this award mechanism are expected to lay the groundwork for future avenues of scientific investigation. The proposed research project should include a well-formulated, testable hypothesis based on strong scientific rationale and study design. The presentation of preliminary and/or published data is not required.
The proposed research project should be innovative. Innovative research may examine a novel paradigm, challenge current paradigms, look at existing problems from novel perspectives, or exhibit other highly creative qualities. Research that is an incremental advance beyond ongoing research and published data is not considered innovative and is not consistent with the intent of this award mechanism. It is the responsibility of the Principal Investigator (PI) to clearly and explicitly articulate how the proposed research project is innovative in the field of MS research.Pre-Application (Preproposal): June 26, 2018Preproposal is required; application submission is by invitation only.
Application: October 18, 2018
Date limite de candidature : 30 octobre 2018
La Fondation pour la recherche médicale lance un appel "Équipes FRM 2019".
Montant : de 200 000 à 400 000 €
Date limite de candidature : 9 novembre 2018